Human periodontal ligament cells facilitate leukocyte recruitment and are influenced in their immunomodulatory function by Th17 cytokine release

Cellular Immunology

Volumn 272, Issue 2, 2012, Pages 137-143

  Konermann, A ^a   Beyer, M ^b   Deschner, J ^a   Allam, J P ^a   Novak, N ^a   Winter, J ^a   Jepsen, S ^a   Jager A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Immunomodulation; Periodontal disease; Periodontal ligament cells; T cells; Th17 cells

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PROGRAMMED DEATH 1 LIGAND 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATORY INFILTRATE; LEUKOCYTE MIGRATION; LYMPHOCYTE DIFFERENTIATION; PATHOGENESIS; PERIODONTAL LIGAMENT; PERIODONTAL LIGAMENT CELL; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; TH17 CELL;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-17; INTERLEUKIN-6; LEUKOCYTES; LYMPHOCYTE ACTIVATION; PERIODONTAL LIGAMENT; PERIODONTITIS; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 83955165300     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.10.020     Document Type: Article

References (42)

1. Gemmell E., Yamazaki K., Seymour G.J. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit. Rev. Oral Biol. Med. 2002, 13:17-34.
2. Gemmell E., Yamazaki K., Seymour G.J. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 2000 2007, 34:14-40.
3. Taubman M.A., Valverde P., Han X., Kawai T. Immune response: the key to bone resorption in periodontal disease. J. Periodontol. 2005, 76:2033-2041.
4. Cochran D.L. Inflammation and bone loss in periodontal disease. J. Periodontol. 2008, 79:1569-1576.
5. Smith R.S., Smith T.J., Blieden T.M., Phipps R.P. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 1997, 151:317-322.
6. Buckley C.D., Pilling D., Lord J.M., Akbar A.N., Scheel-Toellner D., Salmon M. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001, 22:199-204.
7. Kaneda T., Miyauchi M., Takekoshi T., Kitagawa S., Kitagawa M., Shiba H., Kurihara H., Takata T. Characteristics of periodontal ligament subpopulations obtained by sequential enzymatic digestion of rat molar periodontal ligament. Bone 2006, 38:420-426.
8. Brouty-Boyé D., Doucet C., Clay D., Le Bousse-Kerdiles M.C., Lampidis T.J., Azzarone B. Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues. Int. J. Cancer 1998, 76:767-773.
9. Brouty-Boyé D., Pottin-Clémenceau C., Doucet C., Jasmin C., Azzarone B. Chemokines and CD40 expression in human fibroblasts. Eur. J. Immunol. 2000, 30:914-919.
10. Honda T., Aoki Y., Takahashi N., Maekawa T., Nakajima T., Ito H., Tabeta K., Okui T., Kajita K., Domon H., Yamazaki K. Elevated expression of IL-17 and IL-12 genes in chronic inflammatory periodontal disease. Clin. Chim. Acta 2008, 395:137-141.
11. Lester S.R., Bain J.L., Johnson R.B., Serio F.G. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J. Periodontol. 2007, 78:1545-1550.
12. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell mediated tissue damage. Nat. Med. 2007, 13:139-145.
13. Gaffen S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 2009, 9:556-567.
14. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
15. Harrington L.E., Mangan P.R., Weaver C.T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr. Opin. Immunol. 2006, 18:349-356.
16. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
17. Paradis T.J., Cole S.H., Nelson R.T., Gladue R.P. Essential role of CCR6 in directing activated T cells to the skin during contact hypersensitivity. J. Invest. Dermatol. 2007, 128:628-633.
18. Harper E.G., Guo C., Rizzo H., Lillis J.V., Kurtz S.E., Skorcheva I., Purdy D., Fitch E., Iordanov M., Blauvelt A. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 2009, 129:2175-2183.
19. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 2004, 4:762-774.
20. Hwu P., Du M.X., Lapointe R., Do M., Taylor M.W., Young H.A. Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 2000, 164:3596-3599.
21. Nisapakultorn K., Makrudthong J., Sa-Ard-Iam N., Rerkyen P., Mahanonda R., Takikawa O. Indoleamine 2,3-dioxygenase expression and regulation in chronic periodontitis. J. Periodontol. 2009, 80:114-121.
22. Carter L., Fouser L.A., Jussif J., Fitz L., Deng B., Wood C.R., Collins M., Honjo T., Freeman G.J., Carreno B.M. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 2002, 32:634-643.
23. Nishimur H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151.
24. Pinchuk I.V., Saada J.I., Beswick E.J., Boya G., Qiu S.M., Mifflin R.C., Raju G.S., Reyes V.E., Powell D.W. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. Gastroenterology 2008, 135:1228-1237.
25. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
26. Okada H., Kida T., Yamagami H. Identification and distribution of immunocompetent cells in inflamed gingiva of human chronic periodontitis. Infect. Immun. 1983, 41:365-374.
27. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 2007, 96:41-101.
28. Gaffen S.L. Biology of recently discovered cytokines: interleukin-17 - A unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res. Ther. 2004, 6:240-247.
29. Ohyama H., Nishimura F., Meguro M., Takashiba S., Murayama Y., Matsushita S. Counter-antigen presentation: fibroblasts produce cytokines by signaling through HLA class II molecules without inducing T-cell proliferation. Cytokine 2002, 17:175-181.
30. Ohyama H., Kato-Kogoe N., Kuhara A., Nishimura F., Nakasho K., Yamanegi K., Yamada N., Hata M., Yamane J., Terada N. The involvement of IL-23 and the Th17 pathway in periodontitis. J. Dent. Res. 2009, 88:633-638.
31. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
32. Wada N., Menicanin D., Shi S., Bartold P.M., Gronthos S. Immunomodulatory properties of human periodontal ligament stem cells. J. Cell. Physiol. 2009, 219:667-676.
33. Mahanonda R., Sa-Ard-Iam N., Montreekachon P., Pimkhaokham A., Yongvanichit K., Fukuda M.M., Pichyangkul S. IL-8 and IDO expression by human gingival fibroblasts via TLRs. J. Immunol. 2007, 178:1151-1157.
34. Shimabukuro Y., Murakami S., Okada H. Antigen-presenting-cell function of interferon gamma-treated human gingival fibroblasts. J. Periodontal Res. 1996, 31:217-228.
35. Sheng H., Wang Y., Jin Y., Zhang Q., Zhang Y., Wang L., Shen B., Yin S., Liu W., Cui L., Li N. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008, 18:846-857.
36. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 2005, 35:1482-1490.
37. Guo Z., Zheng C., Chen Z., Gu D., Du W., Ge J., Han Z., Yang R. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells. Eur. J. Immunol. 2009, 39:2840-2849.
38. Su X., Ye J., Hsueh E.C., Zhang Y., Hoft D.F., Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J. Immunol. 2010, 184:1630-1641.
39. Svensson M., Kaye P.M. Stromal-cell regulation of dendritic-cell differentiation and function. Trends Immunol. 2006, 27:580-587.
40. Saalbach A., Klein C., Sleeman J., Sack U., Kauer F., Gebhardt C., Averbeck M., Anderegg U., Simon J.C. Dermal fibroblasts induce maturation of dendritic cells. J. Immunol. 2007, 178:4966-4974.
41. Schirmer C., Klein C., von Bergen M., Simon J.C., Saalbach A. Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 2010, 116:1715-1725.
42. Murakami S., Okada H. Lymphocyte-fibroblast interactions. Crit. Rev. Oral Biol. Med. 1997, 8:40-50.